Ignite Creation Date:
2024-05-05 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00510510
Status:
COMPLETED
Last Update Posted:
2012-05-21
First Post:
2007-08-01
Brief Title:
Safety and Tolerability of 28 Days Treatment With Glycopyrronium Bromide NVA237 100 or 200 µg Once a Day in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Sponsor:
Organization:
Novartis